KUHN Elizabeth Profile
KUHN Elizabeth

@Kuhn_Elizabeth7

Followers
135
Following
737
Media
4
Statuses
222

Postdoc @DZNE_en in M.Wagner's team 🇩🇪 | PhD @ChetelatLab 🇨🇵 | #SCD #Neuroimaging #Alzheimer | @SCDPIA communication chair

Bonn, Allemagne
Joined January 2014
Don't wanna be here? Send us removal request.
@Kuhn_Elizabeth7
KUHN Elizabeth
2 years
Interested in participating in a meta-analysis of informant-reported SCD criteria and their links to AD biomarkers? Your cohort assesses informant-reports and Aβ or tau in CU elderly or SCD patients? Join our @SCDPIA working group (A&T and Dyadic pattern cross-projects) [1/3]
1
3
3
@Kuhn_Elizabeth7
KUHN Elizabeth
8 months
RT @StopALZ: Félicitations à @RobindeFlores, lauréat du Prix Joël Ménard 2024 en recherche clinique et translationnelle 🧠! 📷 Découvrez son….
0
7
0
@Kuhn_Elizabeth7
KUHN Elizabeth
9 months
RT @SCDPIA: 📚 Have you come across studies published between January 1st and December 31st, 2024, that you found particularly relevant? Hel….
0
1
0
@Kuhn_Elizabeth7
KUHN Elizabeth
9 months
RT @SCDPIA: 🚨 Starting in 30 minutes! 🚨. Join us for the 30-min Subjective Cognitive Decline Journal Club with @MarkDubbleman, presenting a….
0
1
0
@Kuhn_Elizabeth7
KUHN Elizabeth
9 months
RT @SCDPIA: Looking forward to tomorrow's Journal Club discussion! 📚✨ Still time to register if you haven’t yet—don’t miss out on a great c….
0
1
0
@Kuhn_Elizabeth7
KUHN Elizabeth
9 months
RT @RikOssenkoppele: IWG 2024 vs AA 2024 criteria for Alzheimer disease. A comparison between the recently proposed Alzheimer Association c….
0
18
0
@Kuhn_Elizabeth7
KUHN Elizabeth
9 months
RT @SCDPIA: 🌟 Excited to introduce our Executive Committee for 2024-2026!.We’re thrilled to present the amazing team working in the SCD fie….
0
1
0
@Kuhn_Elizabeth7
KUHN Elizabeth
10 months
RT @M_SuarezCalvet: 📢 POSTDOC position at @biofinder_study @BarcelonaBeta still open! 👩🏽‍💻🧑🏿‍💻👩🏻‍💻🧠📊. 📩 Contact us for more info! . https:….
0
20
0
@Kuhn_Elizabeth7
KUHN Elizabeth
10 months
RT @SCDPIA: 🚨 Join us for the @SCDPIA @ISTAART "Journal Club: Meet the Author" on Nov 6 at 10:00 AM CT! 🧠. 🔗 Read the article: https://t.co….
0
2
0
@Kuhn_Elizabeth7
KUHN Elizabeth
10 months
RT @julie_gonn: ⌛️The 1st edition of #EUMIND is in 1 week. Very much looking forward to these 3 days of science 🧠, networking 🤝 and social….
eu-mind.org
EU-MIND is a brand-new European congress dedicated to neuroimaging of neurodegenerative diseases that will bring together brilliant minds from across Europe and beyond to forge cutting-edge innovat...
0
4
0
@Kuhn_Elizabeth7
KUHN Elizabeth
11 months
RT @mikemalekahmadi: Really excited to host this upcoming webinar on Friday October 11 where @markdbm will present his work on measuring cl….
0
3
0
@Kuhn_Elizabeth7
KUHN Elizabeth
11 months
RT @SCDPIA: 📢 Exciting News!.We currently have 6 active working groups, with some still accepting new members! Got a new idea for a working….
0
3
0
@Kuhn_Elizabeth7
KUHN Elizabeth
11 months
RT @SCDPIA: 📢 Join us TODAY for the Subjective Cognitive Decline PIA All Members Meeting at 9 AM CDT! . 🧠 Don't miss out — there's still ti….
Tweet card summary image
worldtimebuddy.com
0
1
0
@Kuhn_Elizabeth7
KUHN Elizabeth
1 year
It also suggests that Stage 2 AD risk group could be defined in studies relying solely on plasma biomarkers if combined with an established SCD measure. This may facilitate future studies in regions and for individuals without access to invasive or expensive amyloid measurements.
0
0
0
@Kuhn_Elizabeth7
KUHN Elizabeth
1 year
This demonstrates that SCD combined with amyloid positivity is a robust and tangible indicator of clinical Stage 2 of the biological AD continuum.
1
0
0
@Kuhn_Elizabeth7
KUHN Elizabeth
1 year
This was found using different operationalisations of SCD and amyloid (categorical vs dimensional, PET vs plasma Ab42/40). Similar findings were found in the SILCODE even in the absence of a memory clinic consultation (SCD-community).
1
0
0
@Kuhn_Elizabeth7
KUHN Elizabeth
1 year
SCD+Ab+ participants showed steeper cognitive decline or fewer training effects than the other 3 groups in DELCODE and SILCODE combined and stratified.
1
0
0
@Kuhn_Elizabeth7
KUHN Elizabeth
1 year
Super proud and happy to share my first paper published as last author, co-supervising @Kai_Shao_ on the CLoCODE project, a Sino-German collaboration!. Amyloid and SCD jointly predict cognitive decline across Chinese and German cohorts -
Tweet card summary image
alz-journals.onlinelibrary.wiley.com
INTRODUCTION Subjective cognitive decline (SCD) in amyloid-positive (Aβ+) individuals was proposed as a clinical indicator of Stage 2 in the Alzheimer's disease (AD) continuum, but this requires...
1
1
3
@Kuhn_Elizabeth7
KUHN Elizabeth
1 year
RT @INM7_ISN: 📢 Looking for a postdoc to work on. - building fully reproducible QC-pipelines for large scale MRI data.- designing #machinel….
0
56
0